Beta Therapeutics Pty Ltd

Status: Registered
Australian Company Number: 151766817
Australian Business Number: 32151766817
Registration date: July 5, 2011
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Beta Therapeutics Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2011-07-05 and was issued with the 151766817 ACN. Its Australian Business Number is 32151766817. Since 2011-07-14, the company is headquartered in ACT, post code 2601. Beta Therapeutics Pty Ltd was registered for the GST on 2011-07-31. Beta Therapeutics Pty Ltd has been using the Beta Therapeutics Pty Ltd trading name since 2011-07-14 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2011-07-15. found 0 trademarks that mention this company.


Details for ABN 32151766817

Type: Australian Private Company

ABN Status

Status From To
Active July 14, 2011 current

Main Name

Name From To
Beta Therapeutics Pty Ltd July 14, 2011 current

Trading Names

Name From To
Beta Therapeutics Pty Ltd July 14, 2011 current

Main Location

Location From To
ACT 2601 July 14, 2011 current

Goods & Services Tax (GST)

Status From To
Registered July 31, 2011 current


Find company

ACT 2601 Location

2016 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2015 (, and, ©Intellectual Property Government Open Data 2015, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.